Legislation and Legislative Advocacy
The American Hospital Association (AHA) shares resources on health care legislation being considered by the U.S. House and Senate and legislative advocacy opportunities for hospitals and health systems.
Unless overturned, a recent Court of Appeals decision in a False Claims Act case “may force hospitals to adopt fundamental changes to their compensation practices at significant cost and loss of productivity.”
A coalition of 15 health care organizations, including the AHA, today voiced support for the Rural ACO Improvement Act (S. 2648), legislation that would revise the benchmarking formula for the Medicare Shared Savings Program to ensure participating accountable care organizations have an equal…
The Republican Study Committee today announced a proposed alternative to the Affordable Care Act and Democratic proposals for a government-run health care system.
The Centers for Disease Control and Prevention Friday released an update to its 1998 guidelines to prevent and control infection in the health care workplace, including special considerations associated with emergency response personnel and the Americans with Disabilities Act.
The House Energy and Commerce Committee last night approved a revised version of the Lower Prescription Drug Costs Now Act.
The AHA urges Senate appropriators to support federal funding for research and education to reduce violence in communities
Two House committees today marked up revised versions of the Lower Prescription Drug Costs Now Act (H.R. 3) — legislation that would make a series of changes to the Medicare program in an effort to lower the price of prescription drugs.
Congress should pass legislation that protects patients from surprise medical bills and rejects rate setting, hospital leaders said today at an AHA briefing on Capitol Hill.
The Food and Drug Administration last week updated 2017 draft guidance to clarify the categories of clinical and decision support software subject to FDA oversight under the 21st Century Cures Act based on risk.
The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act, H.R. 4538, bipartisan legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals.